Jack Abraham - 06 Aug 2021 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
10%+ Owner
Signature
/s/ Jack Abraham
Issuer symbol
HIMS
Transactions as of
06 Aug 2021
Transactions value $
$0
Form type
4
Filing time
06 Aug 2021, 19:19:16 UTC
Next filing
16 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Exercise of in-the-money or at-the-money derivative security +4,012 +0.56% 721,539 06 Aug 2021 Direct F1, F2
transaction HIMS Class A Common Stock Exercise of in-the-money or at-the-money derivative security +1,559 +0.56% 280,430 06 Aug 2021 See Footnote F1, F3
transaction HIMS Class A Common Stock Exercise of in-the-money or at-the-money derivative security +7,280 +0.56% 1,309,256 06 Aug 2021 See Footnote F1, F4
transaction HIMS Class A Common Stock Exercise of in-the-money or at-the-money derivative security +5,442 +0.56% 978,653 06 Aug 2021 See Footnote F1, F5
transaction HIMS Class A Common Stock Exercise of in-the-money or at-the-money derivative security +45,626 +0.56% 8,204,647 06 Aug 2021 See Footnote F1, F6
transaction HIMS Class A Common Stock Exercise of in-the-money or at-the-money derivative security +46,238 +0.56% 8,314,803 06 Aug 2021 See Footnote F1, F7
transaction HIMS Class A Common Stock Exercise of in-the-money or at-the-money derivative security +24,449 +0.56% 4,396,480 06 Aug 2021 See Footnote F1, F8
transaction HIMS Class A Common Stock Sale -2,941 -0.41% 718,598 06 Aug 2021 Direct F2, F9
transaction HIMS Class A Common Stock Sale -1,143 -0.41% 279,287 06 Aug 2021 See Footnote F3, F9
transaction HIMS Class A Common Stock Sale -5,337 -0.41% 1,303,919 06 Aug 2021 See Footnote F4, F9
transaction HIMS Class A Common Stock Sale -3,989 -0.41% 974,664 06 Aug 2021 See Footnote F5, F9
transaction HIMS Class A Common Stock Sale -33,444 -0.41% 8,171,203 06 Aug 2021 See Footnote F6, F9
transaction HIMS Class A Common Stock Sale -33,893 -0.41% 8,280,910 06 Aug 2021 See Footnote F7, F9
transaction HIMS Class A Common Stock Sale -17,922 -0.41% 4,378,558 06 Aug 2021 See Footnote F8, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Warrants (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -4,012 -100% $0* 0 06 Aug 2021 Class A Common Stock 4,012 Direct F1, F2
transaction HIMS Warrants (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -1,559 -100% $0* 0 06 Aug 2021 Class A Common Stock 1,559 See Footnote F1, F3
transaction HIMS Warrants (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -7,280 -100% $0* 0 06 Aug 2021 Class A Common Stock 7,280 See Footnote F1, F4
transaction HIMS Warrants (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -5,442 -100% $0* 0 06 Aug 2021 Class A Common Stock 5,422 See Footnote F1, F5
transaction HIMS Warrants (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -45,626 -100% $0* 0 06 Aug 2021 Class A Common Stock 45,626 See Footnote F1, F6
transaction HIMS Warrants (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -46,238 -100% $0* 0 06 Aug 2021 Class A Common Stock 46,238 See Footnote F1, F7
transaction HIMS Warrants (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -24,449 -100% $0* 0 06 Aug 2021 Class A Common Stock 24,449 See Footnote F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised.
F2 These securities are owned directly by the Reporting Person. The securities reported herein as indirectly owned by the Reporting Person are held directly and indirectly by the entities referred to in footnotes (3) through (7) below (collectively, the "Controlled Entities"). The Reporting Person disclaims beneficial ownership of the securities held by the Controlled Entities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting Person is the beneficial owner of such securities for any other purpose. The Reporting Person disclaims the existence of a "group" with or among any of the Controlled Entities.
F3 Securities are owned by Atomic Incentives, LLC ("Incentives"). Atomic Labs, LLC ("Labs") is the sole member of Incentives. The Reporting Person is the sole manager of Labs and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Incentives.
F4 Securities are owned by Atomic Labs I, L.P. ("Labs I"). Atomic Labs GP I, LLC ("Labs GP I") is the general partner of Labs I. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owner by Labs I.
F5 Securities are owned by Atomic Labs I-B, L.P. ("Labs I-B"). Labs GP I is the general partner of Labs I-B. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs I-B.
F6 Securities are owned by F41 Investments LLC ("F41"). The Reporting Person is the managing member of F41 and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by F41.
F7 Securities are owned by Atomic Labs II, L.P. ("Labs II"). Atomic Labs GP II, LLC ("Labs GP II") is the general partner of Labs II. The Reporting Person is a managing member of Labs GP II and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs II.
F8 Securities are held by The Jack Abraham 2020 Irrevocable Trust A, which is a trust the holdings of which may be attributable to the Reporting Person.
F9 Represents withholding of shares of Class A Common Stock in connection with the cashless exercises referred to in footnote (1) above.